Indoco Remedies Limited — Updates, 23-05-2025: Press Release

Indoco Remedies has announced a board meeting to discuss the financial results for the quarter and half-year. The company secured final USFDA approval for its generic Allopurinol Tablets USP 200 mg, manufactured at its Goa facility, enhancing its presence in the US generics market. This approval supports Indoco’s growth strategy, leveraging its global reach and diverse therapeutic portfolio to strengthen expansion in key international and domestic markets.